APA (7th ed.) Citation

Stellbrink, H., Orkin, C., Arribas, J. R., Compston, J., Gerstoft, J., Van Wijngaerden, E., . . . Pearce, H. (2010). Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from the ASSERT Study. Clinical infectious diseases, 51(8), 963-972. https://doi.org/10.1086/656417

Chicago Style (17th ed.) Citation

Stellbrink, Hans-Jürgen, et al. "Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine Versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from the ASSERT Study." Clinical Infectious Diseases 51, no. 8 (2010): 963-972. https://doi.org/10.1086/656417.

MLA (9th ed.) Citation

Stellbrink, Hans-Jürgen, et al. "Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine Versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from the ASSERT Study." Clinical Infectious Diseases, vol. 51, no. 8, 2010, pp. 963-972, https://doi.org/10.1086/656417.